Topic timeline
Health research
Trials, approvals, public health · 21 notes
November 2026
October 2026
- FDA grants accelerated approval for first plasmid DNA immunotherapy, Voceryq, for adult RRPVerified
- Study Finds Fruit and Veggie Scraps Are Rich in Dietary FiberVerified
- Video decision aid boosts advance care planning for seniors with advanced kidney diseaseUnsupported claims
- New HS Management Guidelines Issue 37 RecommendationsUnsupported claims
- Cochrane review finds workplace ergonomics offer little benefit for CANSVerified
- Heme shown to inhibit clot‑dissolving enzyme, study findsUnsupported claims
- Bispecific ADC doubles PFS in HR+/HER2‑ breast cancerVerified
- Johns Hopkins APL's OsteoSEE Wins R&D 100 Award for Early Fracture DetectionVerified
- SGLT2 Inhibitors Show Mortality and Kidney Benefits but Higher Cardiac Risks in Adults 80+ with CKDVerified
- UCL trial shows abiraterone may halve death risk in high‑risk localized prostate cancerVerified
- Discrimination Linked to Mental‑Health Crisis Among U.S. LGBTQ+ YouthVerified
- Canada's under‑5s largely active and well‑rested, but screen‑time compliance lowPartly verified
- Study links autoimmune rheumatic diseases to higher long COVID riskVerified
- FDA approves Hibsago, first antisense drug for chronic hepatitis BPartly verified
- Risk‑taking behavior precedes increased drinking in AUD, study findsVerified
- Greener anesthesia could cut OR emissions by half and lower drug costs 40%Verified
- Patient‑centered financial navigation cuts cancer care toxicityUnsupported claims
- Medical Xpress reports on PET imaging's growing role in Alzheimer's drug selectionUnsupported claims